C105H121Br5ClF5LiN19O21 — CID 163797062
lithium;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-cyclopropyl-1-oxopropan-2-yl]-7-bromo-5-fluoro-1H-indole-2-carboxamide;7-bromo-N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-cyclopropyl-1-oxopropan-2-yl]-5-fluoro-1H-indole-2-carboxamide;7-bromo-5-fluoro-1H-indole-2-carboxylic acid;ethyl 7-bromo-5-fluoro-1H-indole-2-carboxylate;methyl (2S)-2-[[(2S)-2-amino-3-cyclopropylpropanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-2-[[(2S)-2-[(7-bromo-5-fluoro-1H-indole-2-carbonyl)amino]-3-cyclopropylpropanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrochloride (PubChem CID 163797062) has the molecular formula C105H121Br5ClF5LiN19O21 and a molecular weight of 2522.14 g/mol. Its IUPAC name is lithium;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-cyclopropyl-1-oxopropan-2-yl]-7-bromo-5-fluoro-1H-indole-2-carboxamide;7-bromo-N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-cyclopropyl-1-oxopropan-2-yl]-5-fluoro-1H-indole-2-carboxamide;7-bromo-5-fluoro-1H-indole-2-carboxylic acid;ethyl 7-bromo-5-fluoro-1H-indole-2-carboxylate;methyl (2S)-2-[[(2S)-2-amino-3-cyclopropylpropanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-2-[[(2S)-2-[(7-bromo-5-fluoro-1H-indole-2-carbonyl)amino]-3-cyclopropylpropanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrochloride.
| Compound Name | lithium;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-cyclopropyl-1-oxopropan-2-yl]-7-bromo-5-fluoro-1H-indole-2-carboxamide;7-bromo-N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-cyclopropyl-1-oxopropan-2-yl]-5-fluoro-1H-indole-2-carboxamide;7-bromo-5-fluoro-1H-indole-2-carboxylic acid;ethyl 7-bromo-5-fluoro-1H-indole-2-carboxylate;methyl (2S)-2-[[(2S)-2-amino-3-cyclopropylpropanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-2-[[(2S)-2-[(7-bromo-5-fluoro-1H-indole-2-carbonyl)amino]-3-cyclopropylpropanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrochloride |
|---|---|
| PubChem CID | 163797062 |
| Molecular Formula | C105H121Br5ClF5LiN19O21 |
| Molecular Weight | 2522.14 g/mol |
| Exact Mass | 2515.47 |
| IUPAC Name | lithium;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-cyclopropyl-1-oxopropan-2-yl]-7-bromo-5-fluoro-1H-indole-2-carboxamide;7-bromo-N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-cyclopropyl-1-oxopropan-2-yl]-5-fluoro-1H-indole-2-carboxamide;7-bromo-5-fluoro-1H-indole-2-carboxylic acid;ethyl 7-bromo-5-fluoro-1H-indole-2-carboxylate;methyl (2S)-2-[[(2S)-2-amino-3-cyclopropylpropanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-2-[[(2S)-2-[(7-bromo-5-fluoro-1H-indole-2-carbonyl)amino]-3-cyclopropylpropanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrochloride |
| SMILES | CCOC(=O)c1cc2cc(F)cc(Br)c2[nH]1.COC(=O)[C@H](C[C@@H]1CCCNC1=O)NC(=O)[C@@H](N)CC1CC1.COC(=O)[C@H](C[C@@H]1CCCNC1=O)NC(=O)[C@H](CC1CC1)NC(=O)c1cc2cc(F)cc(Br)c2[nH]1.Cl.N#C[C@H](C[C@@H]1CCCNC1=O)NC(=O)[C@H](CC1CC1)NC(=O)c1cc2cc(F)cc(Br)c2[nH]1.NC(=O)[C@H](C[C@@H]1CCCNC1=O)NC(=O)[C@H](CC1CC1)NC(=O)c1cc2cc(F)cc(Br)c2[nH]1.O=C(O)c1cc2cc(F)cc(Br)c2[nH]1.[Li+].[OH-] |
| InChI | InChI=1S/C24H28BrFN4O5.C23H27BrFN5O4.C23H25BrFN5O3.C15H25N3O4.C11H9BrFNO2.C9H5BrFNO2.ClH.Li.H2O/c1-35-24(34)19(9-13-3-2-6-27-21(13)31)30-22(32)17(7-12-4-5-12)29-23(33)18-10-14-8-15(26)11-16(25)20(14)28-18;24-15-10-14(25)7-13-9-18(28-19(13)15)23(34)30-17(6-11-3-4-11)22(33)29-16(20(26)31)8-12-2-1-5-27-21(12)32;24-17-10-15(25)7-14-9-19(29-20(14)17)23(33)30-18(6-12-3-4-12)22(32)28-16(11-26)8-13-2-1-5-27-21(13)31;1-22-15(21)12(8-10-3-2-6-17-13(10)19)18-14(20)11(16)7-9-4-5-9;1-2-16-11(15)9-4-6-3-7(13)5-8(12)10(6)14-9;10-6-3-5(11)1-4-2-7(9(13)14)12-8(4)6;;;/h8,10-13,17,19,28H,2-7,9H2,1H3,(H,27,31)(H,29,33)(H,30,32);7,9-12,16-17,28H,1-6,8H2,(H2,26,31)(H,27,32)(H,29,33)(H,30,34);7,9-10,12-13,16,18,29H,1-6,8H2,(H,27,31)(H,28,32)(H,30,33);9-12H,2-8,16H2,1H3,(H,17,19)(H,18,20);3-5,14H,2H2,1H3;1-3,12H,(H,13,14);1H;;1H2/q;;;;;;;+1;/p-1/t13-,17-,19-;12-,16-,17-;13-,16-,18-;10-,11-,12-;;;;;/m0000...../s1 |
| InChIKey | GVZFNGLXUZULDQ-AKGXRRNUSA-M |
| XLogP | 10.24 |
| TPSA | 638.15 Ų |
| H-Bond Donors | 19 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 36 |
| Heavy Atoms | 157 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2522.14 |
| LogP ≤ 5 | 10.24 |
| H-Bond Donors ≤ 5 | 19 |
| H-Bond Acceptors ≤ 10 | 22 |
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|